A double Philadelphia chromosome-positive chronic myeloid leukemia patient, co-expressing P210BCR-ABL1 and P195BCR-ABL1 isoforms

被引：6
作者：
Vinhas, Raquel [1 ]
Lourenco, Alexandra [2 ]
Santos, Susana [2 ]
Ribeiro, Patricia [2 ]
Silva, Madalena [2 ]
de Sousa, Aida Botelho [2 ]
Baptista, Pedro V. [1 ]
Fernandes, Alexandra R. [1 ]
机构：
[1] Univ Nova Lisboa, Dept Ciencias Vida, UCIBIO, Fac Ciencias & Tecnol, Campus Caparica, Lisbon, Portugal
[2] Hosp Capuchos CHLC, Serv Hematol, Lisbon, Portugal
来源：
HAEMATOLOGICA | 2018年 / 103卷 / 11期
关键词：
E6A2; BCR-ABL; FUSION TRANSCRIPT; CML PATIENT; IMATINIB; THERAPY;
D O I：
10.3324/haematol.2018.192534
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E549 / E552
页数：4
相关论文
共 15 条
  • [1] CML with e6a2 BCR-ABL1 transcript: an aggressive entity?
    Beel, Karolien Anne
    Lemmens, Jan
    Vranckx, Hilde
    Maertens, Johan
    Vandenberghe, Peter
    [J]. ANNALS OF HEMATOLOGY, 2011, 90 (10) : 1241 - 1243
  • [2] Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR/ABL fusion transcript, JAK2 negativity and complete response to imatinib
    Breccia, Massimo
    Cannella, Laura
    Diverio, Daniela
    Streponi, Paola
    Nanni, Mauro
    Stefanizzi, Caterina
    Natalino, Fiammetta
    Mecarocci, Sergio
    Alimena, Giuliana
    [J]. LEUKEMIA RESEARCH, 2008, 32 (01) : 177 - 180
  • [3] Colla S, 2004, HAEMATOLOGICA, V89, P611
  • [4] Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV
    Fabarius, Alice
    Leitner, Armin
    Hochhaus, Andreas
    Mueller, Martin C.
    Hanfstein, Benjamin
    Haferlach, Claudia
    Goehring, Gudrun
    Schlegelberger, Brigitte
    Jotterand, Martine
    Reiter, Andreas
    Jung-Munkwitz, Susanne
    Proetel, Ulrike
    Schwaab, Juliana
    Hofmann, Wolf-Karsten
    Schubert, Joerg
    Einsele, Hermann
    Ho, Anthony D.
    Falge, Christiane
    Kanz, Lothar
    Neubauer, Andreas
    Kneba, Michael
    Stegelmann, Frank
    Pfreundschuh, Michael
    Waller, Cornelius F.
    Spiekermann, Karsten
    Baerlocher, Gabriela M.
    Lauseker, Michael
    Pfirrmann, Markus
    Hasford, Joerg
    Saussele, Susanne
    Hehlmann, Ruediger
    [J]. BLOOD, 2011, 118 (26) : 6760 - 6768
  • [5] Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience
    Kantarjian, Hagop
    O'Brien, Susan
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Quintas-Cardama, Alfonso
    Shan, Jenny
    Rios, Mary Beth
    Ravandi, Farhad
    Faderl, Stefan
    Kadia, Tapan
    Borthakur, Gautam
    Huang, Xuelin
    Champlin, Richard
    Talpaz, Moshe
    Cortes, Jorge
    [J]. BLOOD, 2012, 119 (09) : 1981 - 1987
  • [6] Nilotinib and allogeneic stem cell transplantation in a chronic myeloid leukemia patient with e6a2 and e1a2 BCR-ABL transcripts
    Langabeer, Stephen E.
    Crampe, Mireille
    Kelly, Johanna
    Fadalla, Kamal
    Connaghan, Gerard
    Conneally, Eibhlin
    [J]. LEUKEMIA RESEARCH, 2010, 34 (08) : E204 - E205
  • [7] Double Philadelphia-chromosome: a resistance factor on the imatinib mesylate therapy for chronic myeloid leukemia
    Otero, L.
    Ornellas, M. H.
    Dobbin, J.
    Fernandez, T. de Souza
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 (04) : 346 - 348
  • [8] Complete molecular response of e6a2 BCR-ABL-positive acute myeloid leukemia to imatinib then dasatinib
    Ritchie, David S.
    McBean, Michelle
    Westerman, David A.
    Kovalenko, Sergey
    Seymour, John F.
    Dobrovic, Alexander
    [J]. BLOOD, 2008, 111 (05) : 2896 - 2898
  • [9] IDENTIFICATION OF E6A2 BCR-ABL FUSION IN A PHILADELPHIA-POSITIVE CML WITH MARKED BASOPHILIA: IMPLICATIONS FOR TREATMENT STRATEGY
    Rohon, Peter
    Divoka, Martina
    Calabkova, Lenka
    Mojzikova, Renata
    Katrincsakova, Beata
    Rusinakova, Zuzana
    Lapcikova, Anna
    Raida, Ludek
    Faber, Edgar
    Jarosova, Marie
    Divoky, Vladimir
    Indrak, Karel
    [J]. BIOMEDICAL PAPERS-OLOMOUC, 2011, 155 (02): : 187 - 190
  • [10] BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis
    Schultheis, B
    Wang, L
    Clark, RE
    Melo, JV
    [J]. LEUKEMIA, 2003, 17 (10) : 2054 - 2055
12